Literature DB >> 21781508

[Treatment guidelines of chronic myeloid leukemia].

.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21781508

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN： 0253-2727


× No keyword cloud information.
  2 in total

1.  Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapy.

Authors:  Leiming Xia; Wei Qian; Mingzhen Yang; Qingsheng Li; Fei Liu; Yanyan Xie
Journal:  Onco Targets Ther       Date:  2015-09-07       Impact factor: 4.147

2.  [Comparison of nilotinib vs imatinib as frontline therapy in newly diagnosed patients with chronic myeloid leukemia in chronic phase].

Authors:  L Yu; Y Z Qin; Y Y Lai; H X Shi; X J Huang; Y Hou; Q Jiang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-12-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.